Aurora kinase as a putative target to tick control
Bruno Moraes1,2, Helga Gomes3, Luiz Saramago2
1Laboratório de Bioquímica de Artrópodes Hematófagos, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, RJ, Brazil.
Parasitology
|November 14, 2024
Summary
Aurora kinases are crucial for cell division. In ticks, specific sequences in Rm-AURKA offer potential for targeted inhibition, impacting parasite control.
Area of Science:
- Molecular Biology
- Parasitology
- Biochemistry
Background:
- Aurora kinases (AURK) are serine-threonine proteins vital for cell cycle regulation, including mitosis.
- Mammals possess three AURK isoforms (A, B, C) with distinct cell cycle roles.
- Two AURK sequences (Rm-AURKA, Rm-AURKB) were identified in the cattle tick *Rhipicephalus microplus*, with highest expression in ovaries.
Purpose of the Study:
- To investigate the role and potential inhibition of Aurora kinases in the cattle tick *Rhipicephalus microplus*.
- To identify species-specific differences in AURK sequences for targeted therapeutic development.
- To explore the efficacy of a pan-AURK inhibitor against tick cells.
Main Methods:
- Transcriptome analysis to identify AURK sequences in *R. microplus*.
- Bioinformatic analysis of deduced amino acid sequences, comparing tick and vertebrate AURKs.
- Cell viability assays using a pan-AURK inhibitor (CCT137690) on tick cell lines.
- In silico molecular docking to assess inhibitor-target interactions.
Main Results:
- Non-conserved threonine residues, essential for vertebrate AURK function, were identified in *R. microplus* sequences.
- The pan-AURK inhibitor CCT137690 reduced viability in the BME26 tick cell line.
- In silico analysis revealed exclusive interaction sites between CCT137690 and Rm-AURKA.
Conclusions:
- The identified non-conserved residues and exclusive interaction sites in Rm-AURKA present opportunities for developing species-specific inhibitors.
- Targeting tick Aurora kinases could lead to novel strategies for controlling ectoparasites like *Rhipicephalus microplus*.
- Further research into these exclusive regions can facilitate the design of targeted therapies against ticks.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


